Inflammatix
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
540 Oakmead Pkwy, Sunnyvale, California,...Phone Number
(650) 443-3030Website
www.inflammatix.comRevenue
$40.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Inflammatix
Inflammatix is a molecular diagnostics company that is reimagining diagnostics by reading the patient's immune system to deliver rapid results that improve patient care and reduce major public health burdens. The company's initial focus is on acute infections and sepsis, where its tests combine proprietary biomarkers and advanced machine learning to help physicians quickly get the right treatments to the right patients.Explore more
Inflammatix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Inflammatix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Inflammatix had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Inflammatix
Check if Inflammatix has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Inflammatix launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Inflammatix has new funding data
Earning: See what the market has to say on Inflammatix recently announced quarterly report
Check out if Inflammatix is spiking on competitors!
Inflammatix, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Inflammatix
Find 2 more new buyers
Compare Similar Companies to Inflammatix
Compare insights from companies similar to Inflammatix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Inflammatix is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Inflammatix is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Inflammatix.
Inflammatix financials insights
Gather financial insights about Inflammatix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Other Financing Round
$6M
2020
Series C
$32M
Grant
$7.4M
2021
Series D
$102M
Grant
$12.1M
2024
Series E
$57M
Inflammatix Tech Stack
A closer look at the technologies used by Inflammatix
See more technologies
Most Recent Scoops
Event
Person-Based
Timothy Sweeney, Co-Founder & Chief Executive Officer, appeared on a podcast called "The Bio Report" on 12/10/2025. Topics discussed include Sepsis, Point-of-Care Test, Immune Response.
Events, Podcast
Person-Based
New Hire
Executive Move
Executive Moves, New Hire
Hiring Plans
Inflammatix has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Open Position
Inflammatix News & Media
Inflammatix Announces Three Landmark Publications in Nature Medicine that Redefine Acute Infection and Sepsis Diagnosis and Treatment
Inflammatix cracks the code of sepsis with an AI-powered test that outperforms the standard of care SEPSIS-SHIELD study validates TriVerity™ as a breakthrough test that can transform hospital triage by providing early clarity on both infection type and illness severity SUNNYVALE, Calif.,...Inflammatix Data in Journal of Clinical Microbiology Validate Accuracy, Robustness, and Ease of Use of TriVerity™ Test System
Publication demonstrates superior analytical performance of TriVerity in assessing patients with suspected acute infection or sepsis SUNNYVALE, Calif., Sept. 2, 2025 /PRNewswire/ -- Inflammatix, a pioneering host response diagnostics company, today announced the publication of analytical...Inflammatix's TriVerity™ Test Secures NTAP Reimbursement from CMS for First-in-Class Severity Score Working in Concert with Bacterial and Viral Insights
SUNNYVALE, Calif., Aug. 4, 2025 /PRNewswire/ -- Inflammatix, a leader in host-response diagnostics, today announced that its TriVerity™ Test has been granted New Technology Add-On Payment (NTAP) reimbursement by the Centers for Medicare & Medicaid Services (CMS) for fiscal year 2026. The...Inflammatix Names Martín Vazquez as Chief Operating Officer to Drive National Scale-Up of TriVerity™ Test System
Seasoned medtech executive joins as hospital adoption accelerates for breakthrough diagnostic in acute infection and sepsis care SUNNYVALE, Calif., June 10, 2025 /PRNewswire/ -- Inflammatix, a leader in AI-powered immune response diagnostics, today announced the appointment of Martín...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Inflammatix
Sign Up For FreeTo access detailed company insights
Inflammatix is a molecular diagnostics company that is reimagining diagnostics by reading the patient's immune system to deliver rapid results that improve patient care and reduce major public health burdens. The company's initial focus is on acute infections and sepsis, where its tests combine proprietary biomarkers and advanced machine learning t... Read More
